A new co-innovation lab in the San Francisco Bay area will see Lilly and NVIDIA scientists work alongside each other to fuel ...

Anthropic has introduced Claude for Healthcare, a suite of artificial intelligence (AI)-based tools to assist healthcare ...

Edwards Lifesciences has announced that the US District Court for the District of Columbia has approved an injunction motion ...

The BEST division, a subsidiary of Bruker, has confirmed two multi-year MRI superconductor supply agreements with global ...

Haemonetics has acquired Vivasure, a developer of next-generation technology for percutaneous vessel closure, in a deal worth ...

FineHeart has raised €83m ($96.6m) in public and private financing towards advancing the development of its implantable ...

The US Food and Drug Administration (FDA) is moving to relax regulatory requirements for low risk health and wellness ...

Enodia Therapeutics has raised $25m in seed funding to advance a small-molecule platform for targeted protein degradation ...

NAMSA has acquired select assets of Labcorp’s early development medical device testing business, aligning with .

CSA Medical has submitted a PMA application for its RejuvenAir System, a device-based therapy intended to treat chronic ...

BrightHeart has raised €11m ($12.8m) to advance commercialisation efforts for its AI-based prenatal congenital heart defect ...

Medical Devices includes a session from a regulatory expert on how companies can align their research between regions.